- DOI:
-
https://doi.org/10.57187/4922
Original article
Vol. 156 No. 10 (2026)
Dispensing behaviour in relation to opioid-containing antitussives: a survey among community pharmacists
-
Cite this as:
-
Swiss Med Wkly. 2026;156:4922
-
Published
-
22.10.2026
Summary
BACKGROUND: Opioid-containing antitussives are used to symptomatically treat dry coughs but are also consumed recreationally as euphoriant drugs, especially by teenagers and young adults. To curb misuse, in 2019 opioid-containing antitussives in Switzerland were relisted from over-the-counter to requiring a physician’s prescription or direct dispensing by a pharmacist.
AIM: This study aimed to elucidate how this regulatory change impacted the dispensing behaviour of practicing community pharmacists in Switzerland in relation to opioid-containing antitussives.
METHODS: We conducted a cross-sectional survey. The survey consisted of 24 questions and was distributed online via national and cantonal pharmacists’ associations’ mailing lists to community pharmacists in German, French and Italian. The survey was analysed descriptively. No outcomes for hypothesis testing were specified.
RESULTS: Our survey was completed by 405 practicing community pharmacists. Most pharmacists reported that the upregulation of opioid-containing antitussives to prescription products led to less frequent (85.8%) and more cautious (74.3%) dispensing. The misuse potential was considered the most important deciding factor when dispensing opioid-containing antitussives. Despite being widely considered as effective (78.4%), opioid-containing antitussives were reported to be used mainly as second and third choice for dry cough, with the most popular first-line choice being butamirate-containing antitussives (43.0%). Notably, French-speaking participants showed the most restrictive attitude towards opioid-containing antitussives, with 49.6% reporting not dispensing them at all.
CONCLUSIONS: Most pharmacists perceived a change in dispensing patterns after the upregulation, with the new dispensing competencies being rated as beneficial by some and as burdensome by others. There were regional differences in attitudes towards opioid-containing antitussives which seemed to be influenced by neighbouring countries.
References
- 1. Jones S. Teens and Cough Medicine Abuse [Internet]. Available from: https://www.webmd.com/parenting/teens-cough-medicine-abuse
- 2. Cough Medicine Abuse by Teens - Health Encyclopedia [Internet]. University of Rochester Medical Center. Available from: https://www.urmc.rochester.edu/encyclopedia/content.aspx?contenttypeid=1&contentid=2617
- 3. Miuli A, Stigliano G, Lalli A, Coladonato M, D'Angelo L, Esposito F. "Purple Drank" (Codeine and Promethazine Cough Syrup): A Systematic Review of a Social Phenomenon with Medical Implications. J Psychoactive Drugs. 2020 Oct 19;52(5):453–62.
- 4. Burns JM, Boyer EW. Antitussives and substance abuse. Subst Abuse Rehabil. 2013 Nov 6;4:75–82.
- 5. Elwood W. Leaning on syrup - The misuse of opioid cough syrup in Houston. 1999.
- 6. Quednow BB, Steinhoff A, Bechtiger L, Ribeaud D, Eisner M, Shanahan L. High Prevalence and Early Onsets: Legal and Illegal Substance Use in an Urban Cohort of Young Adults in Switzerland. Eur Addict Res. 2021 Dec 3;28(3):186–98.
- 7. Steinhoff A, Shanahan L, Bechtiger L, Zimmermann J, Ribeaud D, Eisner MP. When Substance Use Is Underreported: Comparing Self-Reports and Hair Toxicology in an Urban Cohort of Young Adults. J Am Acad Child Adolesc Psychiatry. 2023 Jul;62(7):791–804.
- 8. Jahresbericht zu den respiratorischen Viren 2023/2024 [Internet]. Bundesamt für Gesundheit; 2024. Available from: https://www.infovac.ch/docs/public/jahresbericht-zu-den-respiratorischen-viren-2023-2024.pdf
- 9. Bevölkerung: Panorama - 2024 [Internet]. Bundesamt für Statistik; 2024. Available from: https://www.bfs.admin.ch/asset/de/33027163
- 10. Margan Koletić Ž, Pavličić B, Ključević Ž, Soldo A, Puljak L. Pharmacists' experience with patients suspected to be addicted to over-the-counter codeine and their attitudes towards potential remediation strategies: a cross-sectional study. BMC Psychiatry. 2025 Apr 30;25(1):442.
- 11. Federal Office of Public Health. Simplified provision of List B medicinal products [Internet]. 2025. Available from: https://www.bag.admin.ch/bag/en/home/medizin-und-forschung/heilmittel/abgabe-von-arzneimitteln.html
- 12. R Core Team. R: A language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2022. Available from: https://www.R-project.org/
- 13. RStudio Team. RStudio: Integrated Development for R [Internet]. RStudio; 2020. Available from: http://www.rstudio.com/
- 14. Wickham H. ggplot2: Elegant Graphics for Data Analysis. Springer-Verlag New York; 2016. Available from: https://ggplot2.tidyverse.org
- 15. Wickham H, Averick M, Bryan J, Chang W, McGowan LD, François R. Welcome to the Tidyverse. J Open Source Softw. 2019 Nov 21;4(43):1686.
- 16. Sievert C. Interactive Web-Based Data Visualization with R, plotly, and shiny. Chapman and Hall; 2020. Available from: https://plotly-r.com
- 17. Sharma A, Minh Duc NT, Luu Lam Thang T, Nam NH, Ng SJ, Abbas KS. A Consensus-Based Checklist for Reporting of Survey Studies (CROSS). J Gen Intern Med. 2021 Oct 1;36(10):3179–87.
- 18. Gasparovic L, Stämpfli D, Chaudhry S, Tadrous M, Burden AM. Opioid-containing antitussives in Switzerland: a descriptive cross-sectional time-series analysis of pharmacy sales 2013–2022. SMW. 2025 Jun 25;155:4188.
- 19. Janousch C, Eggenberger L, Steinhoff A, Johnson-Ferguson L, Bechtiger L, Loher M. Words versus Strands: Reliability and Stability of Concordance Rates of Self-Reported and Hair-Analyzed Substance Use of Young Adults over Time. Eur Addict Res. 2024 Nov 19:1–15.
- 20. Ministère du Travail de la Santé et des Solidarités. Agnès Buzyn décide d'inscrire la codéine et d'autres dérivés de l'opium à la liste des médicaments disponibles uniquement sur ordonnance [Internet]. 2017. Available from: https://sante.gouv.fr/archives/archives-presse/archives-communiques-de-presse/article/agnes-buzyn-decide-d-inscrire-la-codeine-et-d-autres-derives-de-l-opium-a-la
- 21. Agenzia Italiana del Farmaco. Destrometorfano [Internet]. Available from: https://medicinali.aifa.gov.it/it/#/it/risultati?query=DESTROMETORFANO%20(PRINCIPIO%20ATTIVO)&exact=true&soggettoAPrescrizione=false
- 22. Ministerio della Salute. Tabelle delle sostanze stupefacenti e psicotrope [Internet]. Available from: https://www.salute.gov.it/portale/medicinaliStupefacenti/dettaglioContenutiMedicinaliStupefacenti.jsp?lingua=italiano&id=3729&area=sostanzeStupefacenti&menu=vuoto&tab=1
- 23. Bundesinstitut für Arzneimittel und Medizinprodukte. AMIce - Medicinal Product Information System [Internet]. Available from: https://portal.dimdi.de/amguifree/am/search.xhtml
- 24. Perraudin C, Cohidon C, Maes K, Niquille A, Berger J. Les pharmacies dans les soins de première ligne en Suisse. Actual Pharm. 2025 Jan;64(642):28–32.
- 25. Bolser DC, Davenport PW. Codeine and cough: an ineffective gold standard. Curr Opin Allergy Clin Immunol. 2007 Feb;7(1):32–6.
- 26. Morice A, Kardos P. Comprehensive evidence-based review on European antitussives. BMJ Open Respir Res. 2016 Aug;3(1):e000137.
- 27. Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database of Systematic Reviews. 2014 Nov 24;2014(11). doi:10.1002/14651858.CD001831.pub5
- 28. Krüger K, Gehrke-Beck S, Holzinger F, Heintze C. S3-Leitlinie Akuter und chronischer Husten. 2021 Feb.
- 29. Morice AH. Over-the-counter cough medicines: New approaches. Pulm Pharmacol Ther. 2015 Dec;35:149–51.
- 30. National Institute for Health and Care Excellence. Cough (acute): antimicrobial prescribing [Internet]. National Institute for Health and Care Excellence; 2024. Available from: https://www.nice.org.uk/guidance/ng120
- 31. Giuranno M, von Wartburg E, Allemann S. Liste B+: Wie ist die Handhabung in der Apotheke?. pharmaJournal. 2021;9.
- 32. pharmaSuisse. Fakten und Zahlen Schweizer Apotheken 2023 [Internet]. 2023. Available from: https://pharmasuisse.org/system/files/media/documents/2023-11/A6_de_Fakten_Zahlen_2023_web.pdf
- 33. Bakken BK, Gaither CA, Doucette WR, Witry MJ, Kreling DH, Schommer JC. An intersectional review of discrimination and harassment experiences in pharmacy: Findings from the 2019 National Pharmacist Workforce Survey. J Am Pharm Assoc. 2021 Sep;61(5):522–32.
- 34. Penzak SR, Durham SH, Phillippe HM, Fox BI. Knowledge of Kratom among Alabama Pharmacists. Pharmacy. 2023 Dec 30;12(1):6.
- 35. Stewart D, Paudyal V, Cadogan C, Hazen A, Okuyan B, Lutters M. A survey of the European Society of Clinical Pharmacy members' research involvement, and associated enablers and barriers. Int J Clin Pharm. 2020;42(4):1073–87.
- 36. Westrick SC, Patterson BJ, Kader MS, Rashid S, Buck PO, Rothholz MC. National survey of pharmacy-based immunization services. Vaccine. 2018 Sep 5;36(37):5657–64.